FIELD: chemistry.
SUBSTANCE: description is given of new diazabicyclic aryl derivatives, with general formula I: its enantiomers, or mixture of enantiomers, or its adjoining pharmaceutical salt, where X and Y independently represent CR2, CR3 or N, where R2 is hydrogen, C1-6alkyl or halogen; and R3 is hydrogen or halogen; and R1 is hydrogen or halogen, CF3, NO2 or phenyl, possibly substituted, group with formula phenyl-Z-(C1-6alkyl)m-, phenyl -C≡C- or pyridyl -Z-(C1-6alkyl)m-, where m equals 0 or 1; Z - O or S, where phenyl and pyridyl are possibly substituted, or R1 and R3 , together with carbon atoms to which they are bonded, form a benzocondensed aromatic carbocyclic ring, which can be substituted. The new compounds are cholinergic ligands of nicotinic acetylcholine receptors.
EFFECT: compounds can be useful for treating such diseases or disorders related to the cholinergic system of the central nervous system, peripheral nervous system etc.
11 cl, 3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
DIAZABICYCLIC ARYL DERIVATIVES AS LIGANDS OF NICOTINIC ACETYLCHOLINE RECEPTORS | 2005 |
|
RU2367665C2 |
DIAZABICYCLIC ARYL DERIVATIVES USED AS MODULATORS OF CHOLINERGIC RECEPTORS | 2005 |
|
RU2368614C2 |
METHODS AND MEDICAL APPLICATIONS | 2018 |
|
RU2788174C2 |
METHODS AND MEDICAL APPLICATIONS | 2018 |
|
RU2788163C2 |
NOVEL DERIVATIVES OF 1,4-DIAZABICYCLOALKANE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2003 |
|
RU2323218C2 |
PYRIDAZINE DERIVATIVE INHIBITOR, METHOD OF ITS PREPARATION AND ITS USE | 2020 |
|
RU2807611C2 |
BENZAMIDE COMPOUNDS | 2019 |
|
RU2801647C2 |
METHOD OF PREPARING 3-HALOGENALKYL-1H- PYRAZOLES | 1996 |
|
RU2169143C2 |
DIKETONE AS INTERMEDIATE FOR 3-HALOGENE-1H-PYRASOLES | 1996 |
|
RU2251543C2 |
INDOLE DERIVATIVE AND FORMAMIDE, METHOD FOR PRODUCTION THEREOF AND USE IN MEDICINE | 2018 |
|
RU2742770C1 |
Authors
Dates
2008-11-20—Published
2004-02-04—Filed